Tryptamine Therapeutics (ASX:TYP) Price-to-Operating-Cash-Flow : (As of Jun. 09, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Tryptamine Therapeutics Price-to-Operating-Cash-Flow?

As of today (2024-06-09), Tryptamine Therapeutics's share price is A$0.022. Tryptamine Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.03. Hence, Tryptamine Therapeutics's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Tryptamine Therapeutics's Price-to-Operating-Cash-Flow or its related term are showing as below:

ASX:TYP's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 25.29
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Tryptamine Therapeutics's Cash Flow from Operations per share for the six months ended in Dec. 2023 was A$0.01. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.03.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 32.30% per year.

During the past 6 years, Tryptamine Therapeutics's highest 3-Year average Operating Cash Flow per Share Growth Rate was 32.30% per year. The lowest was -12.20% per year. And the median was 10.05% per year.

Tryptamine Therapeutics Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Tryptamine Therapeutics's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tryptamine Therapeutics Price-to-Operating-Cash-Flow Chart

Tryptamine Therapeutics Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Tryptamine Therapeutics Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial						-	-	-	-	-

Competitive Comparison of Tryptamine Therapeutics's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Tryptamine Therapeutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tryptamine Therapeutics's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tryptamine Therapeutics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Tryptamine Therapeutics's Price-to-Operating-Cash-Flow falls into.

Tryptamine Therapeutics Price-to-Operating-Cash-Flow Calculation

Tryptamine Therapeutics's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.022	/	-0.026
	=

Tryptamine Therapeutics's Share Price of today is A$0.022.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Tryptamine Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.03.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Tryptamine Therapeutics Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Tryptamine Therapeutics's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Tryptamine Therapeutics (ASX:TYP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tryptamine Therapeutics Ltd (ASX:TYP) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

697 Burke Road, Suite 201, Camberwell, VIC, AUS, 3124

Website

https://www.exopharm.com

Exopharm Ltd is a biopharmaceutical company that engages in the development of regenerative medicine in Australia. The company is engaged in developing and commercializing exosomes as therapeutic agents. The company operates in one segment namely the research and development of biopharmaceutical drugs. Revenue is generated from Australia.

Tryptamine Therapeutics (ASX:TYP) Headlines

No Headlines